Carmichael Hill & Associates’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-23
| Closed | -$1.55K | – | 672 |
|
|
2023
Q4 | $1.55K | Hold |
23
| – | – | ﹤0.01% | 612 |
|
|
2023
Q3 | $1.56K | Hold |
23
| – | – | ﹤0.01% | 603 |
|
|
2023
Q2 | $1.65K | Hold |
23
| – | – | ﹤0.01% | 610 |
|
|
2023
Q1 | $1.6K | Hold |
23
| – | – | ﹤0.01% | 609 |
|
|
2022
Q4 | $1.56K | Sell |
23
-100
| -81% | -$6.78K | ﹤0.01% | 589 |
|
|
2022
Q3 | $7K | Hold |
123
| – | – | ﹤0.01% | 517 |
|
|
2022
Q2 | $8K | Hold |
123
| – | – | ﹤0.01% | 491 |
|
|
2022
Q1 | $8K | Hold |
123
| – | – | ﹤0.01% | 515 |
|
|
2021
Q4 | $7K | Hold |
123
| – | – | ﹤0.01% | 534 |
|
|
2021
Q3 | $7K | Buy |
123
+23
| +23% | +$1.31K | ﹤0.01% | 525 |
|
|
2021
Q2 | $6K | Hold |
100
| – | – | ﹤0.01% | 538 |
|
|
2021
Q1 | $5K | Sell |
100
-50
| -33% | -$2.5K | ﹤0.01% | 539 |
|
|
2020
Q4 | $7K | Hold |
150
| – | – | ﹤0.01% | 493 |
|
|
2020
Q3 | $8K | Hold |
150
| – | – | 0.01% | 455 |
|
|
2020
Q2 | $8K | Buy |
150
+50
| +50% | +$2.67K | 0.01% | 433 |
|
|
2020
Q1 | $4K | Hold |
100
| – | – | ﹤0.01% | 466 |
|
|
2019
Q4 | $5K | Buy |
+100
| New | +$5K | ﹤0.01% | 484 |
|